We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, professional investors have to conduct complex analyses, spend many resources and use tools that are not […] …read more […]
Diversification is a tried-and-true strategy when investing in stocks. Drug maker Sorrento Therapeutics (SRNE) is applying the same thought process in its battle against the coronavirus. The multi-pronged approach involving a search for antiviral therapies, a vaccine and the production of testing kits, has paid off handsomely in the market, with the stock appreciating by 115% year-to-date.Last week, Sorrento revealed more positive details from its COVID-19 vaccine program’s progress. In a pre-clinical trial, the company’s candidate, T-VIVA-19, was able to generate neutralizing antibodies in 80% of mice injected with the vaccine, and thus completely prevent cells from being infected with …read more […]
Over the past few months, Aurora Cannabis (ACB) has taken several steps to enact a U-turn for its ailing business. Along with a reverse stock split to ensure it remains listed on the New York Stock Exchange, it has closed some of its smaller facilities, as well as put the brakes on the construction of two new sites.Another move has been to acquire Reliva, which has given it access to the U.S. CBD space. That acquisition brought with it Reliva’s CEO, Miguel Martin, who Aurora has just appointed as its new Chief Commercial Officer.Weighing in on the appointment, Jeffries analyst …read more […]
A Note From Marc: As many of you know, I recently started a YouTube series called State of the Market.
Last week, I dedicated an entire video to what I call “Forever Dividend Stocks.”
In it, I reveal how to generate enough passive income in retirement that you never have to touch your initial investment.
Click here to watch it.
This was the oddest Fourth of July I’ve experienced since I lived in San Francisco many years ago. At that time, we sat on some rocks overlooking the Bay, trying to watch fireworks in the pea soup thick fog and saying to each other, …read more […]
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […] …read more […]
Victoria Fernandez, Crossmark Global Investments Chief Market Strategist, joined The Final Round to give her outlook for the market and her outlook for second quarter earnings. …read more […]
Below, Investment U’s Technical Options Expert, Bryan Bottarelli, takes a look at the best COVID Vaccine Stock available today.
It seems pretty logical…
You want to own the company that’ll manufacture and supply the United States (and perhaps even the world) with the COVID-19 vaccines, right?
The gains could be enormous – especially on the day that this world-changing news gets announced.
But the problem is…
How do you identify and invest in the one COVID vaccine stock that’ll emerge as the winner?
A simple Google search shows that 23 of the world’s largest biotech and pharma companies are actively working on coronavirus treatments or vaccines.
You …read more […]
Since bottoming out in early April, shares of online talent search company Upwork (UPWK) have been on a relentless forward charge. Over the past 3 months, the stock has added a hefty 90% of muscle.Come to think of it, Upwork’s platform is one particularly suited to these uncertain times. With jobs getting slashed in every sector, Upwork’s gig economy model should be a defensive play in a cloudy macro climate.However, for BTIG analyst Marvin Fong, Upwork’s potential is “underappreciated.” Fong argues a “large TAM (total addressable market) and secular tailwinds will enable Upwork to grow revenue in excess of 15% …read more […]
Stocks closed higher Wednesday as heavily weighed tech stocks continued their run of outperformance, with shares of Apple, Amazon, Netflix and Facebook hitting record highs. Earlier, a report underscoring ongoing US-China tensions and more advances in coronavirus case counts dragged on the S&P 500 and Dow. …read more […]
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge funds and well-known value investors are required to file by the SEC. The 13F […] …read more […]
(Bloomberg) — Like millions of amateur investors across China, Min Hang has become infatuated with the country’s surging stock market.“There’s no way I can lose,” said the 36-year-old, who works at a technology startup and opened her first trading account in Beijing on Tuesday. “Right now, I’m feeling invincible.”Five years after China’s last big equity boom ended in tears, signs of euphoria among the nation’s investing masses are popping up everywhere. Turnover has soared, margin debt is rising at the fastest pace since 2015 and online trading platforms are struggling to keep up. Over the past seven days alone, Chinese …read more […]
VANCOUVER, Washington, Jul 07, 2020 (GLOBE NEWSWIRE via COMTEX) — Results of preclinical study presented today in oral presentation at the 23 International AIDS Conference (AIDS 2020) CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.
